2 Podcast Episodes
TIVO 1 study shows tivozanib an option for renal cell carcinoma: Dr Robert Motzer - Memorial Sloan Kettering Cancer Centre
TIVO 1 study shows tivozanib an option for renal cell carcinoma: Dr Robert Motzer - Memorial Sloan Kettering Cancer Centre
Dr Motzer talks to ecancer at the 2013 ASCO GU symposium. TIVO 1 study shows tivozanib an option for renal cell carcinom... Read more
7 Mar 2013
•
6mins
RCCU1 2008 | Interview with Robert Motzer, MD
RCCU1 2008 | Interview with Robert Motzer, MD
RenalCellCancerUpdate.com – Conversations with Oncology Investigators. Bridging the Gap between Research and Patient Car... Read more
16 Apr 2008
•
34mins